Axios @axios
The Biden administration unveiled 3 drug payment programs aimed at helping reduce patients' out-of-pocket costs, including one that would potentially lower Medicare payments for promising treatments approved by the FDA before clinical trials are complete. https://t.co/lyod9ZgdtT — PolitiTweet.org
